Inotiv, Inc. — Director's Dealing 2021

Jan 12, 2021

SEC Form 4/A — Form 4/A

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2020-03-12

Reporting Person: Neff R Matthew (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-12	Common Shares	P	8497	$3.80	Acquired	40080	Direct
2020-03-13	Common Shares	P	3350	$3.93	Acquired	43430	Direct

Footnotes

F1: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.92 to $3.95, inclusive. The reporting person undertakes to provide to Bioanalytical Systems, Inc., any security holder of Bioanalytical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2: The reporting person is filing this amendment to correct the number of securities reported as purchased on March 12, 2020.